Location of Repository

Seroepidemiology of hepatitis B virus in Addis Ababa Ethiopia: transmission patterns and vaccine control

By A. Abebe, D. James Nokes, A. Dejene, F. Enquselassie, T. Messele and Felicity Cutts

Abstract

A community-based seroepidemiological survey of Addis Ababa, Ethiopia was conducted in 1994 to inform on the transmission dynamics and control of hepatitis B virus (HBV) infection. Venous blood from 4736 individuals under 50 years of age from 1262 households, selected using stratified cluster-sampling, was screened for HBV markers using commercial ELISAs. HBsAg prevalence was 7% (95% CI 6–8), higher in males (9%; 7–10) than females (5%; 4–6). HBeAg prevalence in HBsAg positives was 23% (18–29), and less than 1% of women of childbearing age were HBeAg positive. Overall HBV seroprevalence (any marker), rose steadily with age to over 70% in 40–49 year olds, indicating significant childhood and adult transmission. Estimated instantaneous incidence was 3–4/100 susceptibles/year, higher in males than females in 0–4 year olds, and peaking in early childhood and young adults. The age at which 50% had evidence of infection was around 20 years, and the herd immunity threshold is approximated at 63–77%. Addis Ababa is of intermediate-high HBV endemicity, with negligible perinatal transmission. Our main findings are the identification of a significant difference between males and females in the age-acquisition of HBV infection, and marked differences between age groups in HBV incidence rates. These results should target future research studies of underlying risk factors. Furthermore, we generate a crude estimate of the level of coverage of HBV vaccine that would be required to eliminate the virus from the study population

Topics: RB, RA
Publisher: Cambridge University Press
Year: 2003
OAI identifier: oai:wrap.warwick.ac.uk:775

Suggested articles

Preview

Citations

  1. (1991). A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q
  2. (1985). Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. doi
  3. (1992). Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clinical Infect Dis doi
  4. (1987). Age- and sexrelated study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). doi
  5. (1986). and delta infection in Ethiopia: a serological survey with demographic data. doi
  6. (1998). and sexspecific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. Aids doi
  7. (1992). Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiop Med J
  8. (1996). Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect doi
  9. Epidemiology of heptatitis B virus infection in the rural community of Tip, doi
  10. (2000). Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments. Ethiop Med J
  11. (1996). Field trials of health interventions in developing countries: a toolbox.
  12. (1989). Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization. Rev Infect Dis doi
  13. (2001). Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull WHO
  14. (2000). Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine doi
  15. (1990). Hepatitis B infection in subSaharan Africa. Vaccine doi
  16. (2001). Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med
  17. (1985). Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. doi
  18. (1977). Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterol
  19. (1997). Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. doi
  20. (1991). Infectious diseases of humans: dynamics and control.
  21. (1985). Large-scale survey of hepatitis B virus infection in families. Microbiol Immunol doi
  22. (1992). Mathematical modelling of the immunisation of populations. Rev Med Virol doi
  23. (1988). Measles in developing countries, Part I Epidemiological parameters and patterns. Epidemiol Infect doi
  24. (1993). Modelling longitudinal toxoplasma seroprevalence in Stockholm, Sweden. Parasitol doi
  25. (1983). Occurrence of hepatitis B surface antigen and its antibody in Ethiopian blood-donors. Ethiop Med J
  26. (1984). Population Housing and Census Commission. The doi
  27. (2000). Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model. Epidemiol Infect doi
  28. (1989). Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia. doi
  29. (1987). Prevalence of hepatitis B virus markers HBV seroepidemiology in Ethiopia 769among Ethiopian blood donors: is HBsAg screening necessary? Trop Geogr Med
  30. (1980). Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull WHO
  31. (2000). Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect doi
  32. (1991). Seroepidemiological study for HBV markers and anti-delta in Kenya. East Afr Med J
  33. (1983). Seroepidemiology of Hepatitis B in an urban population of Nairobi, doi
  34. (1997). Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg doi
  35. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect.
  36. (1998). Seroprevalence of viral hepatitis in Tanzanian adults. Trop Med Int Health doi
  37. (1996). Targeted hepatitis B vaccination – a cost effective immunisation strategy for the UK? doi
  38. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan 2000; 15: 408–416. 770 A. Abebe and others doi
  39. (1992). The impact of viral hepatitis on the morbidity and mortality of chronic liver disease and hepatocellular carcinoma in Ethiopia. Ethiop Med J
  40. (1993). The influence of age on the development of the hepatitis B carrier state. doi
  41. (1996). The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med doi
  42. (1996). The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect doi
  43. (1988). Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. doi
  44. (1996). Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses. Trans R Soc Trop Med Hyg doi
  45. (1976). Viral hepatitis during pregnancy in Ethiopia. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.